Ureteral Stents Market
| Report Code: TIPMD00002017 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Ureteral stents are small tubes that are inserted inside the ureter to treat or to avoid a blockage that prevents the flow of urine from the kidney to the bladder. The ureteral stents are most commonly used for the treatment of kidney stones.
The market for ureteral stents is expected to grow significantly in the coming years, owing to the key factors such as rise in the number of the procedures f kidney failure and kidney stone procedures. The rise in the number of the dialysis cases in the male. Rise in the number kidney failure cases in younger population are likely to propel in the forecasted period. The opportunities for the developers are for innovating the material for the stents and to innovate minimally invasive insertion techniques for the stents.
The “Global Ureteral Stents Market Analysis to 2028” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global ureteral stents market with detailed market segmentation by product, application, end user and geography. The global ureteral stents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global ureteral stents market segment is segmented on the basis of product, application, and end user. The product segment includes expandable stents, double pigtail stents and others. On the basis of the application the segment is classified as kidney stones, kidney failure and others. The end user segment is classified as the hospitals & clinics, ambulatory surgical centers, dialysis centers and others.
The ureteral stents market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global ureteral stents market based on product, application and end user. It also provides market size and forecast till 2028 for overall ureteral stents market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds the largest share in the ureteral stents market. The key drivers that are driving the growth of the market are rise in the number of cases kidney failure cases due to the consumption of alcohol. The rise in the number of cases of prostate cancer and other urology cancer. The Asia Pacific is the fastest growing market due to the rise in the awareness of the product among the people. The rise in the number of dialysis cases are likely to propel the growth of the market in the coming future.
The ureteral stents market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The ureteral stents market report also includes the profiles of key ureteral stents manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the ureteral stents market are Boston Scientific Corporation, Cook, Pnn Medical A/S, C. R. Bard, Inc., Applied Medical Resources Corporation, CIA Medical, Olympus America, B. Braun Melsungen AG, Red Leaf Medical, and SURGIMEDIK.